Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antigen-uptake receptors on antigen-presenting cells (APCs), such as dendritic cells and macrophages, are a diverse group of surface proteins that mediate the entry of vaccine components into the immune system. In the context of the Pediacel vaccine, these receptors recognize and internalize various antigens—including diphtheria, tetanus, and pertussis toxoids—often complexed with aluminum phosphate adjuvants (Kool et al., 2008, Nature Medicine). Key receptors involved in this process include C-type lectin receptors (CLRs) like the Mannose Receptor (CD206) and DEC-205, which facilitate the transport of antigens into endosomal compartments for processing (Ghazarian et al., 2011, Current Opinion in Chemical Biology). The aluminum adjuvant enhances this process by promoting the recruitment of APCs to the injection site and facilitating the uptake of antigen-adjuvant complexes through macropinocytosis or phagocytosis (Ghimire et al., 2017, Frontiers in Immunology). Once internalized, the aluminum component can activate the NLRP3 inflammasome, while the protein antigens are proteolytically degraded and presented on MHC molecules to initiate a protective adaptive immune response (Marrack et al., 2009, Nature Reviews Immunology). These receptors are essential for the efficacy of multi-component vaccines like Pediacel, as they bridge the gap between innate recognition and long-term immunological memory.
Internalization of vaccine antigens and adjuvants via receptor-mediated endocytosis or phagocytosis, followed by proteolytic processing and MHC-mediated antigen presentation to T cells.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen-uptake receptors on antigen-presenting cells.